WASHINGTON, D.C. / ACCESS Newswire / December 15, 2025 / Leading national organizations have come together to form the Alliance to Strengthen America's Health Workforce for the Underserved, a ...

The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...

The "Botulinum Toxin in Urology Market Outlook 2026-2034: Market Share and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Botulinum Toxin in Urology Market is valued at USD 1 ...

OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of its newest cell processing and ...

The "Tourette Syndrome Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Tourette Syndrome Drugs Market is projected to witness ...

OlivePoint Capital (“OlivePoint”), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative ...

ATHEN, Griechenland--(BUSINESS WIRE)-- BEKANNTMACHUNG NUR FÜR EUROPÄISCHE MEDIZIN- UND PHARMAZEUTISCHE FACHMEDIEN SOWIE EUROPÄISCHE FINANZMEDIEN GENESIS Pharma, ein regionales Biopharmaunternehmen, da ...

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...

Ophidion, Inc., a biotechnology company pioneering non-invasive delivery of gene-silencing and large-molecule therapeutics to the brain, and Neuronasal, Inc., a clinical-stage company advancing ...

ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as ...

Scribe Therapeutics Inc. (Scribe), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...